Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Net Cash Flow (2023 - 2025)

Historic Net Cash Flow for Medical Group Holdings (SBC) over the last 3 years, with Q3 2025 value amounting to -$21.5 million.

  • Medical Group Holdings' Net Cash Flow fell 20446.54% to -$21.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.1 million, marking a year-over-year decrease of 11104.35%. This contributed to the annual value of $33.4 million for FY2024, which is 4292.44% down from last year.
  • Per Medical Group Holdings' latest filing, its Net Cash Flow stood at -$21.5 million for Q3 2025, which was down 20446.54% from $15.2 million recorded in Q2 2025.
  • Medical Group Holdings' 5-year Net Cash Flow high stood at $99.8 million for Q2 2023, and its period low was -$21.5 million during Q3 2025.
  • Moreover, its 3-year median value for Net Cash Flow was $13.1 million (2024), whereas its average is $16.9 million.
  • In the last 5 years, Medical Group Holdings' Net Cash Flow surged by 19239.79% in 2024 and then crashed by 20446.54% in 2025.
  • Over the past 3 years, Medical Group Holdings' Net Cash Flow (Quarter) stood at $20.9 million in 2023, then plummeted by 102.25% to -$470307.0 in 2024, then tumbled by 4466.05% to -$21.5 million in 2025.
  • Its Net Cash Flow stands at -$21.5 million for Q3 2025, versus $15.2 million for Q2 2025 and $669434.0 for Q1 2025.